Key Highlights
- John Asalone appointed as CEO of Amino Health, succeeding David Vivero, who transitions to Chairman.
- Asalone brings 20 years of experience in scaling software and marketplace companies, including a significant role at GoodRx.
- 2023 marks a significant year for Amino Health with $80 million in financing and a strong focus on simplifying healthcare navigation.
Source: Business Wire
Notable Quotes
- “I joined Amino to advance its mission of transforming how Americans engage with the healthcare system,” – John Asalone, CEO at Amino Health
- “John is an exceptionally gifted leader who has already had a profound impact on Amino’s ability to scale,” – David Vivero, Co-Founder and Chairman at Amino Health
- “Customers particularly value the product’s usability, a strength stemming from the company’s roots in the direct to consumer business,” – Mike Dixon, Managing Partner at Transformation Capital
SoH's Take
John Asalone’s appointment as CEO of Amino Health is a strategic move that aligns with the company’s mission to revolutionize healthcare navigation. His extensive experience in scaling businesses, particularly in the healthcare sector, will be pivotal in advancing Amino Health’s market position. The transition also signifies a natural evolution in leadership, with founder David Vivero stepping into the role of Chairman, ensuring continuity and stability. With the substantial financing secured earlier this year, Amino is well-positioned to tackle the complexities of healthcare navigation, offering innovative solutions to both consumers and businesses. Asalone’s proven track record and commitment to the company’s vision are promising indicators of continued success and growth under his leadership.
